CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,101,000 | -37.8% | 45,100 | -44.9% | 0.00% | -40.0% |
| Q1 2017 | $8,200,000 | +55.2% | 81,900 | +66.7% | 0.01% | +150.0% |
| Q4 2016 | $5,282,000 | -81.5% | 49,132 | -78.6% | 0.00% | -85.7% |
| Q3 2016 | $28,558,000 | +42.9% | 229,420 | +22.1% | 0.01% | +27.3% |
| Q2 2016 | $19,983,000 | +9.7% | 187,955 | +18.1% | 0.01% | +10.0% |
| Q1 2016 | $18,218,000 | +154.2% | 159,127 | +216.2% | 0.01% | +233.3% |
| Q4 2015 | $7,168,000 | -50.9% | 50,320 | -69.1% | 0.00% | -57.1% |
| Q3 2015 | $14,607,000 | -23.8% | 162,620 | -2.3% | 0.01% | -22.2% |
| Q2 2015 | $19,165,000 | +168.0% | 166,419 | +122.3% | 0.01% | +200.0% |
| Q1 2015 | $7,150,000 | +28.6% | 74,853 | -9.5% | 0.00% | +50.0% |
| Q4 2014 | $5,560,000 | +261.5% | 82,708 | +190.2% | 0.00% | – |
| Q3 2014 | $1,538,000 | -27.6% | 28,500 | -40.3% | 0.00% | -100.0% |
| Q2 2014 | $2,124,000 | +107.2% | 47,758 | +61.9% | 0.00% | – |
| Q1 2014 | $1,025,000 | – | 29,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Segantii Capital Management Ltd | 50,000 | $5,288,000 | 5.80% |
| RUDMAN ERROL M | 37,001 | $3,934,000 | 3.76% |
| INDUS CAPITAL PARTNERS, LLC | 349,210 | $37,128,000 | 3.60% |
| WARBURG PINCUS LLC | 1,312,200 | $139,513,000 | 3.04% |
| SPQ Asia Capital Ltd | 96,000 | $10,206,000 | 2.63% |
| OBERWEIS ASSET MANAGEMENT INC/ | 82,775 | $8,801,000 | 2.62% |
| Ativo Capital Management LLC | 94,074 | $10,002,000 | 2.44% |
| Sensato Investors LLC | 99,764 | $10,607,000 | 1.72% |
| Cormorant Asset Management, LP | 112,867 | $12,000,000 | 1.70% |
| BARING ASSET MANAGEMENT Ltd | 131,284 | $13,958,000 | 1.14% |